Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Equity

v3.19.1
Condensed Consolidated Statement of Equity - USD ($)
$ in Thousands
Total
Series B Preferred Stock
Total Shareholders’ Equity
Total Shareholders’ Equity
Series B Preferred Stock
Preferred Stock
Series A Preferred
Preferred Stock
Series B Preferred Stock
Common Stock
Common Stock
Series B Preferred Stock
Additional Paid-in Capital
Additional Paid-in Capital
Series B Preferred Stock
Accumulated Deficit
Noncontrolling Interests
Beginning balance, shares at Dec. 31, 2017         562 1,875,848 8,744,189         635,018
Beginning balance at Dec. 31, 2017 $ 70,596   $ 63,508   $ 453 $ 40,915 $ 87   $ 226,978   $ (204,925) $ 7,088
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Accretion of Series B Preferred Stock discount 170 $ 22   $ 22   $ 22            
Conversion of Series B Preferred Stock to Common Stock, shares           (100)   (62)        
Conversion of Series B Preferred Stock to Common Stock           $ (2)       $ 2    
Conversion of operating partnership units into common stock, shares             (9,706)         (9,706)
Conversion of operating partnership units to Common Stock     64       $ 0   64     $ (64)
Shares Issued             43,459          
Issuance of Common Stock under Share Incentive Plan 330   330       $ 0   330      
Issuance of Common Stock for acquisition of JANAF, shares             150,000          
Issuance of Common Stock for acquisition of JANAF 1,130   1,130       $ 2   1,128      
Adjustment for noncontrolling interest in operating partnership     505           505     (505)
Dividends and distributions (3,207)   (3,207)               (3,207)  
Net Income (1,872)   (1,825)               (1,825) $ (47)
Ending balance, shares at Mar. 31, 2018         562 1,875,748 8,947,416         625,312
Ending balance at Mar. 31, 2018 66,999   60,527   $ 453 $ 40,935 $ 89   229,007   (209,957) $ 6,472
Beginning balance, shares at Dec. 31, 2017         562 1,875,848 8,744,189         635,018
Beginning balance at Dec. 31, 2017 70,596   63,508   $ 453 $ 40,915 $ 87   226,978   (204,925) $ 7,088
Ending balance, shares at Dec. 31, 2018         562 1,875,748 9,511,464         235,032
Ending balance at Dec. 31, 2018 44,255   42,061   $ 453 $ 41,000 $ 95   233,697   (233,184) $ 2,194
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Accretion of Series B Preferred Stock discount 170 $ 22   $ 22   $ 22            
Shares Issued             181,807          
Issuance of Common Stock under Share Incentive Plan 166   166       $ 2   164      
Dividends and distributions (2,589)   (2,589)               (2,589)  
Net Income 655   642               642 $ 13
Ending balance, shares at Mar. 31, 2019         562 1,875,748 9,693,271         235,032
Ending balance at Mar. 31, 2019 $ 42,509   $ 40,302   $ 453 $ 41,022 $ 97   $ 233,861   $ (235,131) $ 2,207